Clinical Trial Update: A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing clevudine versus entecavir in patients with chronic hepatitis B was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Clevudine (clevudine)
• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 4 | Status: TERMINATED